Implementation Intention Planning Guide for FIT Colon Cancer Screening
Part of paid clinical trials in Lebanon, New Hampshire.
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Study ID
- NCT07183046
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Colorectal Cancer Screening
- Fecal Immunochemical Test
Eligibility Criteria
- Sex
- ALL
- Age
- 45 Years - 75 Years
- Healthy Volunteers
- Accepted
Interventions
- Implementation Intention Guide — BEHAVIORALThe intervention is the addition of implementation intention guide document provided with the FIT. This is a one-page piece of paper that was developed by the investigator team and finalized with input/feedback from patient partners. The implementation intention guide includes instructions about the importance of developing a plan to complete FIT. It also includes fillable fields for participants to enter their plan for when to complete, where to store, when to return, and where to return their FIT. Participants will also be able to follow a QR code on the implementation intention guide document to a link to complete an anonymous, electronic version of the guide and share feedback on the intervention.
Study Details
Fecal immunochemical tests (FIT) are a primary method of screening for colorectal cancer (CRC). Implementation intention planning involves encouraging completion or eliminating barriers for the participant to make a plan to complete a behavior or activity. This randomized control study seeks to answer whether the addition of an implementation intention guide impacts behaviors when completing FIT screening. The primary objective includes determining if the implementation intention guide increases completion rate of screening FIT. The secondary objectives is whether this intervention decreases the lab sample rejection rate and reduces the duration between sample collection and laboratory receipt/evaluation of screening FIT.
Key Dates
- Start date
- Oct 1, 2025
- Status verified
- Jul 2025
- Primary completion
- Mar 31, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 1,600 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SCREENING
Arms
- No Intervention: Control Arm (FIT Standard of Care)The Control Arm will receive the fecal immunochemical test (FIT) standard of care. Participants in this arm will be evaluated by their ordering provider about their eligibility and appropriateness for FIT for colorectal cancer screening. If appropriate, these participants will receive the FIT, instructions, and any other documentations always provided to participants receiving FIT in clinical practice. Any follow-up materials or communications with their provider will also follow FIT standard of care. They will not receive any additional document/implementation intention guide with their FIT.
- Experimental: Intervention Arm (FIT Standard of Care with Implementation Intention Guide)The Intervention Arm will receive the fecal immunochemical test (FIT) standard of care and the implementation intention guide one-page document. Participants in this arm will be evaluated by their ordering provider about their eligibility and appropriateness for FIT for colorectal cancer screening. If appropriate, these participants will receive the FIT, instructions, and any other documentations always provided to participants receiving FIT in clinical practice. They will also receive the implementation intention guide being evaluated in this study. Any follow-up materials or communications with their provider will also follow FIT standard of care.
Primary Outcome Measure
FIT completion rate [ Time Frame: Through study completion, approximately 12-18 months ]
Central Contacts
- Audrey H Calderwood, MD, MS603-650-5261
- Timothy McAuliffe, BA
Locations (5)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Dartmouth Hitchcock Clinics, Heater Road Primary Care | Lebanon | New Hampshire | 03766 | Audrey H Calderwood, MD, MS |
| Dartmouth-Hitchcock Medical Center, General Internal Medicine Clinic | Lebanon | New Hampshire | 03766 | Audrey H Calderwood, MD, MS |
| Dartmouth Hitchcock Clinics, Lyme Primary Care Clinic | Lyme | New Hampshire | 03768 | Audrey H Calderwood, MD, MS |
| White River Junction Veterans Affairs Medical Center, Primary Care Clinic | White River Junction | Vermont | 05009 | Douglas Robertson, MD, MPH |
| White River Junction Veterans Affairs Medical Center, VA Mailed FIT Program | White River Junction | Vermont | 05009 | Douglas Robertson, MD, MPH |
Find similar trials in Lebanon, NH
Related Studies
- Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care SettingsEnrolling By Invitation · Rutgers, The State University of New Jersey · New Brunswick, New Jersey
- Impact of Protect Your Colon™ on CRC ScreeningRecruiting · Cedars-Sinai Medical Center · Los Angeles, California
- Evaluating the Efficacy of the eNav Toolkit to Improve Colorectal Cancer ScreeningEnrolling By Invitation · Icahn School of Medicine at Mount Sinai · New York, New York
- Patient Navigation for Colorectal Cancer ScreeningEnrolling By Invitation · Medstar Health Research Institute · Washington D.C., District of Columbia